Skip to main content
Almirall S.A. logo

Almirall S.A. — Investor Relations & Filings

Ticker · ALM ISIN · ES0157097017 LEI · 95980020140005007996 MC Manufacturing
Open in API
Filings indexed 284 across all filing types
Latest filing 2026-02-23 Audit Report / Informat…
Country ES Spain
Listing MC ALM

About Almirall S.A.

http://www.almirall.com

Almirall S.A. is a global biopharmaceutical company specializing in medical dermatology. The company focuses on the research, development, manufacturing, and commercialization of proprietary medicines to address significant unmet needs in skin health. Leveraging scientific innovation, Almirall provides medical solutions designed to improve the well-being and quality of life for patients. Its operations encompass in-house research and development, strategic partnerships, and in-licensing to expand its portfolio of dermatological treatments.

Recent filings

Filing Released Lang Actions
Annual / Quarterly Financial Statement for Almirall S.A. (2026)
Audit Report / Information Classification · 100% confidence The document is an 'Independent Auditor's Report' issued by KPMG for Almirall, S.A. for the fiscal year ended 31 December 2025. It details the auditor's opinion, key audit matters (such as valuation of investments and deferred tax assets), and the responsibilities of the directors and auditors. As it is a standalone audit report and not the full annual report (10-K), it falls under the Audit Report category. FY 2025
2026-02-23 English
Annual Report for Almirall S.A. (2026)
Audit Report / Information Classification · 100% confidence The document is an 'Independent Auditor's Report' issued by KPMG for Almirall, S.A. It explicitly details the audit of consolidated annual accounts, including key audit matters like goodwill, intangible assets, and deferred tax assets. It follows the standard structure of an audit report (Opinion, Basis for Opinion, Key Audit Matters, Responsibilities). Since it is a standalone audit report and not the full Annual Report (10-K) itself, it falls under the Audit Report category. FY 2025
2026-02-23 English
Annual Report (ESEF) for Almirall S.A. (2026)
Audit Report / Information Classification · 100% confidence The document is an 'Informe de Auditoría de Cuentas Anuales Consolidadas' (Independent Auditor's Report on Consolidated Annual Accounts) for Almirall, S.A. for the fiscal year ending December 31, 2025. It includes the auditor's opinion, key audit matters (such as the recoverability of goodwill and deferred tax assets), and responsibilities of the auditors and management. As it is a standalone audit report and not the full annual report itself, it falls under the 'Audit Report / Information' category. FY 2025
2026-02-23 Spanish
Operaciones del contrato de liquidez durante el cuarto trimestre de 2025
Transaction in Own Shares Classification · 100% confidence The document is a report from Almirall, S.A. detailing transactions made under a liquidity contract with Santander Investment Bolsa. It provides a summary table of share purchases and sales for the period of October 1, 2025, to December 31, 2025, followed by a detailed daily breakdown of these transactions. This type of filing, which reports on the company's activity in its own shares via a liquidity provider, is classified as 'Transaction in Own Shares' (POS).
2026-01-15 English
Presentación: J.P. Morgan Healthcare Conference 2026
Investor Presentation Classification · 100% confidence The document is a slide deck presentation from Almirall, S.A. It contains sections such as 'Our growth story in Dermatology', 'Transformational R&D innovation roadmap', and 'Closing remarks'. It includes financial highlights, product pipeline details, and forward-looking statements typical of an investor presentation. It is not a formal financial report (10-K/IR) or a transcript, but rather a strategic presentation intended for investors.
2026-01-09 English
Almirall ha procedido al cierre y desembolso de su emisión de obligaciones simples de rango sénior.
Capital/Financing Update Classification · 100% confidence The document is an official communication from Almirall, S.A. regarding the closing and disbursement of a senior notes issuance (debt financing). It explicitly mentions the nominal amount (250 million euros), interest rate, and maturity date. This falls under the category of capital structure changes and financing activities. It is not a report publication announcement, but rather the announcement of the completion of a financing transaction.
2025-12-17 Spanish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.